IBDEI0DE ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6398,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6398,1,4,0)
 ;;=4^OTHER OVARIAN FAILURE
 ;;^UTILITY(U,$J,358.3,6398,1,5,0)
 ;;=5^256.39
 ;;^UTILITY(U,$J,358.3,6398,2)
 ;;=^330824
 ;;^UTILITY(U,$J,358.3,6399,0)
 ;;=256.4^^44^514^16
 ;;^UTILITY(U,$J,358.3,6399,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6399,1,4,0)
 ;;=4^POLYCYSTIC OVARIES
 ;;^UTILITY(U,$J,358.3,6399,1,5,0)
 ;;=5^256.4
 ;;^UTILITY(U,$J,358.3,6399,2)
 ;;=^96086
 ;;^UTILITY(U,$J,358.3,6400,0)
 ;;=616.10^^44^514^20
 ;;^UTILITY(U,$J,358.3,6400,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6400,1,4,0)
 ;;=4^VAGINITIS NOS
 ;;^UTILITY(U,$J,358.3,6400,1,5,0)
 ;;=5^616.10
 ;;^UTILITY(U,$J,358.3,6400,2)
 ;;=^125233
 ;;^UTILITY(U,$J,358.3,6401,0)
 ;;=627.3^^44^514^21
 ;;^UTILITY(U,$J,358.3,6401,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6401,1,4,0)
 ;;=4^VAGINITIS,ATROPHIC
 ;;^UTILITY(U,$J,358.3,6401,1,5,0)
 ;;=5^627.3
 ;;^UTILITY(U,$J,358.3,6401,2)
 ;;=^270577
 ;;^UTILITY(U,$J,358.3,6402,0)
 ;;=112.1^^44^514^22
 ;;^UTILITY(U,$J,358.3,6402,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6402,1,4,0)
 ;;=4^VAGINITIS,CANDIDAL
 ;;^UTILITY(U,$J,358.3,6402,1,5,0)
 ;;=5^112.1
 ;;^UTILITY(U,$J,358.3,6402,2)
 ;;=^18615
 ;;^UTILITY(U,$J,358.3,6403,0)
 ;;=131.01^^44^514^23
 ;;^UTILITY(U,$J,358.3,6403,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6403,1,4,0)
 ;;=4^VAGINITIS,TRICHOMONAL
 ;;^UTILITY(U,$J,358.3,6403,1,5,0)
 ;;=5^131.01
 ;;^UTILITY(U,$J,358.3,6403,2)
 ;;=^121763
 ;;^UTILITY(U,$J,358.3,6404,0)
 ;;=256.9^^44^514^13
 ;;^UTILITY(U,$J,358.3,6404,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6404,1,4,0)
 ;;=4^OVARIAN DYSFUNCTION NOS
 ;;^UTILITY(U,$J,358.3,6404,1,5,0)
 ;;=5^256.9
 ;;^UTILITY(U,$J,358.3,6404,2)
 ;;=^267882
 ;;^UTILITY(U,$J,358.3,6405,0)
 ;;=239.7^^44^514^4
 ;;^UTILITY(U,$J,358.3,6405,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6405,1,4,0)
 ;;=4^ENDOCRINE/NERV NEO NOS
 ;;^UTILITY(U,$J,358.3,6405,1,5,0)
 ;;=5^239.7
 ;;^UTILITY(U,$J,358.3,6405,2)
 ;;=^267785
 ;;^UTILITY(U,$J,358.3,6406,0)
 ;;=239.5^^44^514^8
 ;;^UTILITY(U,$J,358.3,6406,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6406,1,4,0)
 ;;=4^GU NEOPLASM NOS
 ;;^UTILITY(U,$J,358.3,6406,1,5,0)
 ;;=5^239.5
 ;;^UTILITY(U,$J,358.3,6406,2)
 ;;=^267784
 ;;^UTILITY(U,$J,358.3,6407,0)
 ;;=193.^^44^515^19
 ;;^UTILITY(U,$J,358.3,6407,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6407,1,4,0)
 ;;=4^THYROID CANCER
 ;;^UTILITY(U,$J,358.3,6407,1,5,0)
 ;;=5^193.
 ;;^UTILITY(U,$J,358.3,6407,2)
 ;;=^267296
 ;;^UTILITY(U,$J,358.3,6408,0)
 ;;=240.9^^44^515^4
 ;;^UTILITY(U,$J,358.3,6408,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6408,1,4,0)
 ;;=4^GOITER NOS
 ;;^UTILITY(U,$J,358.3,6408,1,5,0)
 ;;=5^240.9
 ;;^UTILITY(U,$J,358.3,6408,2)
 ;;=^52400
 ;;^UTILITY(U,$J,358.3,6409,0)
 ;;=241.1^^44^515^14
 ;;^UTILITY(U,$J,358.3,6409,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6409,1,4,0)
 ;;=4^MULTINODULAR
 ;;^UTILITY(U,$J,358.3,6409,1,5,0)
 ;;=5^241.1
 ;;^UTILITY(U,$J,358.3,6409,2)
 ;;=^267790
 ;;^UTILITY(U,$J,358.3,6410,0)
 ;;=242.20^^44^515^15
 ;;^UTILITY(U,$J,358.3,6410,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6410,1,4,0)
 ;;=4^MULTINODULAR,TOXIC
 ;;^UTILITY(U,$J,358.3,6410,1,5,0)
 ;;=5^242.20
 ;;^UTILITY(U,$J,358.3,6410,2)
 ;;=^267801
 ;;^UTILITY(U,$J,358.3,6411,0)
 ;;=242.00^^44^515^7
 ;;^UTILITY(U,$J,358.3,6411,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6411,1,4,0)
 ;;=4^GRAVES DISEASE
 ;;^UTILITY(U,$J,358.3,6411,1,5,0)
 ;;=5^242.00
 ;;^UTILITY(U,$J,358.3,6411,2)
 ;;=^267793
 ;;^UTILITY(U,$J,358.3,6412,0)
 ;;=244.9^^44^515^12
 ;;^UTILITY(U,$J,358.3,6412,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6412,1,4,0)
 ;;=4^HYPOTHYROIDISM NOS
